Metraipolis › archive › dc_8cc9a1cbdbee

RAD51 protein is a predictor of chemosensitivity and survival prognosis in patients with advanced high-grade serous ovarian cancer undergoing neoadjuvant… — Europe PMC PMID:41199843

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41199843
DOI
10.3389/fonc.2025.1548889
License (as archived)
solo-consultazione
Archived
2026-11-09T03:35:17.914Z
SHA-256 of the archived text
7e7e10f3239d9191d402fcfd2e4bc1d10456f84371a410804e4cd08cfcb7ad8f
Stable URL of this page
https://metraipolis.com/documento/dc_8cc9a1cbdbee

How to cite

RAD51 protein is a predictor of chemosensitivity and survival prognosis in patients with advanced high-grade serous ovarian cancer undergoing neoadjuvant… — Europe PMC PMID:41199843 — Europe PMC (en), https://europepmc.org/article/MED/41199843 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8cc9a1cbdbee (Metraipolis archive dc_8cc9a1cbdbee, sha256 7e7e10f3239d9191d402fcfd2e4bc1d10456f84371a410804e4cd08cfcb7ad8f)
BibTeX
@misc{dc8cc9a1cbdbee,
  title = {RAD51 protein is a predictor of chemosensitivity and survival prognosis in patients with advanced high-grade serous ovarian cancer undergoing neoadjuvant… — Europe PMC PMID:41199843},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41199843},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8cc9a1cbdbee; sha256 7e7e10f3239d9191d402fcfd2e4bc1d10456f84371a410804e4cd08cfcb7ad8f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41199843. Agents can read the archived copy with the MCP tool read_document.